• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Akoya Biosciences Inc (NQ: AKYA )

    2.580 +0.220 (+9.32%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 109,305
    Open 2.380
    Bid (Size) 2.450 (2)
    Ask (Size) 2.580 (9)
    Prev. Close 2.360
    Today's Range 2.380 - 2.590
    52wk Range 1.880 - 6.310
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    A Closer Look at 4 Analyst Recommendations For Akoya Biosciences
    Via Benzinga
    AKYA Stock Earnings: Akoya Biosciences Meets EPS, Misses Revenue for Q2 2024
    AKYA stock results show that Akoya Biosciences met analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    -46.03%
    -46.03%
    1 Month
    +7.95%
    +7.95%
    3 Month
    +31.30%
    +31.30%
    6 Month
    -53.01%
    -53.01%
    1 Year
    -50.86%
    -50.86%

    More News

    Read More
    Akoya Biosciences Reports Second Quarter 2024 Financial Results
    From Akoya Biosciences, Inc.
    Via GlobeNewswire
    Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences
    From Akoya Biosciences, Inc.
    Via GlobeNewswire
    Analyst Scoreboard: 4 Ratings For Akoya Biosciences
    Via Benzinga
    Recap: Akoya Biosciences Q4 Earnings
    Via Benzinga
    Earnings Outlook For Akoya Biosciences
    Via Benzinga
    Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    AKYA Stock Earnings: Akoya Biosciences Misses EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Akoya Biosciences Reports First Quarter 2024 Financial Results
    From Akoya Biosciences, Inc.
    Via GlobeNewswire
    Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
    From Akoya Biosciences, Inc.
    Via GlobeNewswire
    Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts
    From Akoya Biosciences, Inc.
    Via GlobeNewswire
    Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows
    From Akoya Biosciences, Inc.
    Via GlobeNewswire
    Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024
    From Akoya Biosciences, Inc.
    Via GlobeNewswire
    Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
    From Akoya Biosciences, Inc.
    Via GlobeNewswire
    AKYA Stock Earnings: Akoya Biosciences Beats EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook
    From Akoya Biosciences, Inc.
    Via GlobeNewswire
    Earnings Scheduled For March 4, 2024
    Via Benzinga
    Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference
    From Akoya Biosciences, Inc.
    Via GlobeNewswire
    Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases
    From Akoya Biosciences, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.